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ABSTRACT 
 
Background 
Over 4,000 women die from cervical cancer every year in the United States. Over half are 
due to lack of routine screening, which disproportionally affects racial/ethnic minority 
women. Home-based HPV self-testing may increase screening among hard to reach 
women. Little is known regarding women’s reactions to receiving HPV self-test results 
on the phone, an important consideration in determining the feasibility of self-testing. 
This study’s objective is to determine women’s reactions to their HPV self-test results, 
and the delivery method, stratified by race/ethnicity. 
 
Methods  
Under-screened, low-income North Carolina women from 10 counties were recruited. A 
total of 202 women (78 White; 124 Black) collected and returned their self-test sample, 
and completed an acceptability questionnaire. Analyses examined reactions based on 
HPV self-test results at baseline and follow-up, and predictors of feeling afraid of what 
the HPV self-tests would say about their health.  
 
Results 
White women reported being more worried about getting cervical cancer compared to 
Black women. Women who received positive HPV self-test results self-reported being 
more likely to feel embarrassed, worried, depressed, and liking help understanding their 
results, than those HPV self-test negative. Women underestimated the need for help with 
interpreting their results.  Women were more likely to report being afraid of what the 
self-test results would say about their health if they had lower educational attainment; 
were divorced, widowed, and separated; and self-reported history of genital warts.   
 
Conclusions  
These findings can inform cervical cancer messaging that emphasizes underserved 
populations’ understanding of their heightened risk and the importance of screening.  
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INTRODUCTION 
 Invasive cervical cancer (ICC) is one of the most common cancers affecting women 
in the United States (US).  In 2016, an estimated 12,990 women in the US will be 
diagnosed with ICC and 4,120 women will die from this largely preventable disease. (1) 
Over 50 percent of new ICC cases occur among women who have been screened 
infrequently or not at all. (2) Black and Hispanic/Latina women, particularly those who 
are elderly, uninsured, poor, or otherwise underserved, carry the heaviest burden of ICC. 
(3,4) Self-collection HPV tests that can be performed in a variety of settings including the 
home may be a potential strategy to reach racial/ethnic minority women who are less 
likely to participate in regular clinical screenings.   
Virtually all ICC cases are caused by infection with high-risk oncogenic strains of 
the sexually transmitted human papillomavirus (HPV), but are preventable through 
vaccination and regular screening. (1,3,5) While access to routine screening has led to an 
overall decline in the morbidity and mortality attributable to ICC, Hispanic/Latina 
women are still less likely to have participate in routine screening and have a higher risk 
of cervical cancer compared to White and Black women. (1,3,4) US cancer statistics from 
2012 report that Hispanic/Latina and Black women have the highest incidence of cervical 
cancer compared to all other races at 9.5 cases per 100,000 people and 9.0 cases per 
100,000 people respectively, compared to 7.1 cases per 100,000 among White women. 
(6) Additionally, the 2012 death rates for cervical cancer for Hispanic/Latino and Black 
women are 2.7 per 100,000 people and 3.7 per 100,000 respectively, compared to 2.1 per 
100,000 people for White women. (6) Along with a lower prevalence of screening, this 
disparity in mortality can also be attributed to later stage of diagnosis. (7) 
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 Previously identified barriers to cervical cancer screening include a lack of 
continuum of health care due to include lack of health insurance and poor access to 
medical services. (3,8) Furthermore, minority race/ethnicity, low educational attainment, 
low income, limited health literacy regarding the benefits of screening, and age are well-
documented barriers to screening. (3,6) Emotional barriers to screening include feelings 
of embarrassment or discomfort with pelvic examination, shame or fear of 
embarrassment by results, and confusing information about cervical cancer screening. (9) 
Existing literature also cites a lack of culturally appropriate care and perceived racism 
from health care providers as significant barriers to regular screening. (3,4) 
Hispanic/Latina women also report fatalism, stigma, and perceived lack of social support 
networks associated with cancer diagnoses as significant barriers. (4) 
The Papanicolaou test or Pap smear, which uses a sample of cervical cells to 
detect cellular abnormalities, has been a universally endorsed method for screening 
cervical cancer. (10) However, due to the relatively low sensitivity of the Pap smear for 
the detection of high-grade precancerous cervical lesions, nearly one-third of new 
invasive cervical cancer cases may be attributed to false negative Pap results. (10) The 
US Food and Drug Administration (FDA) recently approved an HPV test as a primary 
cervical cancer screening option and can be offered in conjunction with a Pap smear. 
(11,12) The U.S. Preventive Services Task Force (USPSTF) currently recommends HPV 
testing in conjunction with pap smears every 5 years for women aged 30-65 to increase 
screening sensitivity and allow for longer intervals between screenings. (13) 
Given the accuracy of the HPV test, there is interest among clinicians and 
researchers to use it as a primary screening method among under screened women.  Self-
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collection of cervico-vaginal samples for HPV testing as an initial screen for cervical 
cancer can be a viable option, with follow-up screening by Pap smear cytology or 
colposcopy for women found to be HPV positive via self-collection. (14–18) Self-
collection has been shown to be nearly as sensitive as physician-based HPV testing and 
more sensitive (though less specific) than pap smears alone. (19,20) The self-test allows 
women to use a device in their home on their own to collect cervico-vaginal specimens 
for HPV testing, and may be a good way to reach vulnerable populations and increase 
initial cervical cancer screening in populations with limited resources and low cervical 
cancer screening rates by potentially overcoming logistic, emotional, financial, and 
stigma-related barriers to attending regular screenings.  
While barriers to initial screening among under screened populations in the 
United States are well documented and existing literature indicates a generally high 
acceptability of a self-test in US and international populations, little is known about the 
emotional response to receiving results of screenings conducted using the self-test. (21) 
Limited research conducted on the psychosocial effects of cervical cancer screening 
results in clinical settings indicate that women with positive HPV test results experience 
feelings of distress, anxiety of having to disclose the results to their sexual partner, and 
embarrassment of having a sexually transmitted infection. (9,22–24) Psychosocial 
responses to screening, both before and after, are an important consideration as negative 
feelings may present a barrier to subsequent screening opportunities among under 
screened women. Furthermore, it raises questions regarding result delivery, especially to 
underserved racial/ethnic minority women, and if they are appropriately counseled 
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regarding the meaning of their results and the need for follow-up screenings in a 
culturally competent manner. (25) 
Thus, we present data here to determine women’s reactions to self-test results 
delivered by phone among low-income, under-screened women within the target age for 
HPV testing (30 years or older). Our aim was to determine how North Carolina women 
who are at high risk for cervical cancer, completed self-collection of cervico-vaginal 
samples with mailed kits and returned the samples by mail, react to their HPV self-test 
results and the delivery method, stratified by race/ethnicity.  
 
METHODS 
Target population and sample 
 Between January 2010 and September 2011, recruitment of underserved women 
was conducted in 10 North Carolina counties (Wake, Durham, Harnett, Guilford, Wayne, 
Cumberland, Robeson, Richmond, Hoke and Scotland) via the distribution of flyers, 
referral of callers from the United Way 2-1-1 social assistance hotline, and newspaper 
and radio advertisements. Potential participants were screened for eligibility by calling a 
toll-free telephone hotline, staffed 24 hours per day by trained personnel from the 
American Sexual Health Association (ASHA). Women were eligible to participate if they 
(i) had not received a Pap smear in the previous 4 years, (ii) lived in North Carolina, (iii) 
were not pregnant, (iv) had not undergone a hysterectomy, (v) were between 30 and 65 
years of age, and (vi) met one of the following income criteria: (a) had children that 
qualified for the federal school lunch program, (b) had Medicaid or Medicare Part B 
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insurance, or (c) were uninsured and living at or below 250% of the federal poverty level 
(determined by household income and size). 
The initial sample included women who took and returned their self-samples, 
reported their race/ethnicity, and participated in the acceptability questionnaire (n=224). 
Only women who identified as non-Hispanic White or non-Hispanic Black were included 
in the final analysis (n=202). Women who identified as Hispanic (n=12), Asian (n=2), 
American Indian or Alaska Native (n=6), or mixed race/ethnicity (n=2), were not 
included; the study was not powered to include these races/ethnicities individually. A 
sensitivity analysis concluded that including these women in a third racial category called 
“other” did not significantly alter the results, and they were subsequently dropped from 
the sample (Figure 1). 
Procedures  
 Eligible women were mailed a self-collection kit containing a brush for collecting 
a cervico-vaginal sample collection device, a vial of preservation media, simple 1-page 
illustrated instructions for collecting the sample, and a prepaid mailer to return their self-
collected specimen for HPV testing. The package also contained a list with contact 
information of local clinics that perform low-cost or free Pap smears, and informed 
consent and HIPAA authorization forms for participants to complete and return. When 
results were available, the ASHA call center called participants to provide their HPV self-
collection results.  During this call, agents encouraged participants to obtain a clinic-
based Pap smear; provided them with information where to obtain a free or low-cost Pap 
in their county; and administered a questionnaire to assess beliefs, knowledge, and 
acceptability of self-collection. After the study received notification of Pap smear 
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completion or after two months without notification, participants were contacted to 
complete a follow-up questionnaire. Study participants received grocery store gift cards: 
(i) $30 for returning the self-collection kit and completing the acceptability questionnaire, 
(ii) $10 for reporting completion of a Pap smear (either via provided postcard or 
verbally), (iii) and $5 for completing the follow-up questionnaire.  
 The study protocol was reviewed and approved by the University of North 
Carolina at Chapel Hill Institutional Review Board. 
Measures 
 Self-collection sample: Participants collected cervico-vaginal samples using a 
Viba brush (Rovers Medical Devices, BV; Oss, The Netherlands) and placed the brush 
head in a 10-ml. vial of Scope mouthwash, previously determined to be a stable 
preservation medium. [16]). Specimens were de-identified, frozen, and shipped in weekly 
batches to the Cleveland Clinic laboratory (Cleveland, OH) for high-risk HPV infection 
testing using the Hybrid-Capture II HPV test (QIAGEN Corporation, Gaithersburg, MD). 
 Acceptability questionnaire (AQ): Questionnaire items focused on participants’ 
perceptions of their experience completing HPV testing by self-collection (referred to as 
“self-test”), including the clarity of instructions, use of the brush, attitudes and/or 
concerns about the test, and returning the self-collection kit by mail (primary outcome of 
the study). Questions also gauged the quality of and attitudes towards the self-collection 
experience, as well as feelings regarding returning the self-collected sample by mail. In 
addition, the survey assessed participants’ HPV knowledge, past medical and 
reproductive history, socio-demographic factors, and responses to receiving HPV results. 
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            Follow-up questionnaire: In the follow-up questionnaire (FQ), women were asked 
whether and where they had undergone a Pap smear to follow-up on their HPV self-
collection. Items addressed their experiences with the Pap smear (e.g., “How much pain, 
if any, did you have when you got the Pap smear?”), their past histories of cervical 
disease and its evaluation and treatment, their attitudes and concerns with Pap smears 
(e.g. “I worried that the Pap smear exam might not be clean” and “My husband or sexual 
partner did not want me to get a Pap smear”) and their responses to their personal Pap 
smear results. The follow-up questionnaire also reassessed their responses to the HPV 
self-test results.  
Data analysis 
Demographic data, time since last Pap smear, and attitudes towards HPV and 
cervical cancer were assessed for 202 women. Initial reactions to self-test results and 
result delivery based on 12 selected questions from the AQ (10) and FQ (2).   The AQ 
questions were analyzed for a total of 194 women who received either a positive (n=29) 
or negative (n=165) result; this included 73 White women and 121 Black women.  The 
FQ questions were analyzed for women who completed both the AQ and FQ (n=93) and 
received either a positive (n=20) or negative (n=73) result; this included 35 White women 
and 58 Black women. A two-sided t-test was used to compare variation in the continuous 
variables and Pearson’s chi-squared test was conducted to compare variation in 
categorical variables, by race (White and Black).  
To assess changes in responses to the reaction-specific questions with time, 
responses to questions regarding result delivery that appeared in both the AQ (designated 
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as baseline) and FQ were analyzed (n= 95). Differences in reporting between baseline 
and follow-up were assessed using Pearson’s chi-squared test. 
The final portion of the analysis assessed demographic and health behavior 
predictors of women’s concern regarding what their self-test results would say about their 
health. This question appeared in the AQ and offers additional context on the 
psychosocial impact of interpreting the self-test results (n=197). Twenty-two categorical 
variables from the acceptability questionnaire including race and age were included based 
on their mention in existing literature on cervical cancer risk. Participants who indicated 
that they strongly or moderately agreed that they were afraid of what the self-test results 
would say about their health were attributed a value of 1 while participants who indicated 
that they strongly or moderately disagreed were attributed a value of 0. Crude odds ratios 
with 95% confidence interval was calculated for each covariate, followed by odds ratios 
with 95% confidence intervals adjusted for race and age, two documented covariates of 
cervical cancer screening. All results were considered statistically significant at p<0.05.  
All analyses were conducted in Stata Statistical Software, Release 14.0 (Stata Corp, 
College Station, Texas, USA).  
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Figure 1: Final analysis sample - Acceptability of a mailed HPV† self-resting kit for use 
with high risk, low income women in North Carolina, 2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
†HPV=Human Papillomavirus, a sexually transmitted infection causing virtually all cervical cancer 
cases 
Screened for 
Study eligibility 
N=905 
 
Ineligible (n = 478, 52.8%) 
• Not within 30-64 age range; n= 68 
• Pap within 4 years; n = 262 
• Hysterectomy; n = 83 
• Pregnant; n = 4 
• Above 250 percentage of federal 
poverty line; n = 48 
• Missing; n=13  
Study eligible and sent self-test kit  
n = 427 
Returned  self-test kit 
n = 275 (64%) 
Participated in 
acceptability 
questionnaire and 
reported race/ethnicity 
n = 224 (52%) 
Demographic data 
for non-Hispanic 
Black, non-Hispanic 
White women only 
n=202 (47%) 
Non-Hispanic Black, 
non-Hispanic White 
women with HPV 
self-test positive or 
negative results  
n=194 
 
Non-Hispanic Black, 
and non-Hispanic 
White women with 
non-missing data for 
AQ49: “I was afraid 
what the self-test 
results would say 
about my health “ 
n=197 
Non-Hispanic Black, 
non-Hispanic White 
women who completed 
AQ and FQ for 
comparison of reaction 
to self-test at baseline 
and follow-up  
n=95 
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RESULTS 
Table 1:  Demographic data for 202 infrequently screened women in North Carolina† 
†N=202 includes female participants who completed the acceptability questionnaire. Those identifying as 
Hispanic/Latina, Asian, American Indian/Alaska Native, or “other” were not included in analyses 
SD=standard deviation from median value; GED= General Education Development certification 
‡P-values based on 2-sided t-test for time since last pap and age; remaining p-values based on Pearson’s 
Chi-squared test. All calculated using non-missing data only 
§ Statistically significant at α=0.05 comparing mean number of live births and urbanicity between White 
and Black women 
 
 Among 202 participating women (78 White; 124 Black), the median age was 44 
years for both races (Table 1). The median time since last Pap was 5 years (range 4-13 
 Overall 
N (range/ %) White Black P-value
‡ 
N (%) 202 78 (38.6%) 124 (61.4%)  
Time Since Last Pap (years) 
      Mean (SD) 
      Median (Range) 
 
5.9  (2.6) 
5 (4-13) 
 
6.3 (2.9) 
5 (4-13) 
 
5.6 (2.3) 
5 (4-11) 
 
0.07 
 
Age (years) 
     Mean (SD) 
     Median (Range) 
 
43.8 (8.3) 
44 (30-64) 
 
43.1 (8.1) 
44 (30-64) 
 
44.2 (8.5) 
44 (30-44) 
 
0.40 
Number of live births 
     Mean (SD) 
     Median (Range) 
 
2.4 (1.6) 
2 (0-8) 
 
2 (1.4) 
2 (0-6) 
 
2.6 (1.7) 
2 (0-8) 
 
0.02§ 
Education 
    Less than GED or HS diploma 
    High school diploma/ GED  
    Some college or more 
 
42 (20.8%) 
76 (37.1%) 
75 (37.1%) 
 
19 (24.4%) 
22 (28.2%) 
32 (41%) 
 
23 (18.5%) 
53 (43.73%) 
43 (34.7%) 
 
 
0.21 
Marital status 
    Married or living as married 
    Divorced/ separated/ widowed 
    Single never married 
 
57 (28.2%) 
52 (25.7%) 
85 (42.1%) 
 
28 (35.9%) 
21 (26.9%) 
28 (35.9%) 
 
29 (23.4%) 
31 (25%) 
57 (46%) 
 
 
0.1 
Annual household income (USD) 
    <$10,000 
    $10,000-$20,000 
    $20,000+ 
 
87 (43.1%) 
70 (34.6%) 
29 (14.4%) 
 
30 (38.5%) 
35 (44.9%) 
10 (12.8%) 
 
57 (46%) 
35 (28.2%) 
19 (15.3%) 
 
 
0.06 
Urbanicity 
    Rural 
    Urban 
 
40 (19.8%) 
162 (80.2%) 
 
21 (26.9%) 
57 (73.1%) 
 
19 (15.3%) 
105 (84.7%) 
 
0.04§ 
Insurance Status 
   None 
   Medicaid 
   Military/Blue Cross/Other 
 
126 (62.4%) 
51 (25.6%) 
18 (8.9%) 
 
50 (64.1%) 
18 (23.1%) 
9 (11.5%) 
 
76 (61.3%) 
33 (26.6%) 
9 (7.3%) 
 
 
0.39 
Religious preference 
   No religion 
   Baptist 
   Christian, non-Baptist 
   Other religion 
 
21 (10.4%) 
75(37.1%) 
60 (29.7%) 
8 (4%) 
 
12 (15.4%) 
25 (32%) 
27(34.6%) 
1 (1.3%) 
 
9 (7.3%) 
50 (40.3%) 
33 (26.6%) 
7 (5.6%) 
 
 
 
0.11 
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years). Participating White women had a slightly lower mean number of live births (n=2) 
than Black women (n=2.6), p=0.02.  Distribution of educational attainment, insurance 
status, and religious preference did not appear to notably differ between white and black 
participants. Black women were more likely to live in urban areas (84.7%) compared to 
White women (73.1%), p=0.04.  
Table 2: Attitudes and beliefs of infrequently screened women (n=202) † 
 
†N=202 includes participants who completed the acceptability questionnaire. Those identifying as 
Hispanic/Latina, Asian, American Indian/Alaska Native, or other not included in analysis 
HPV=Human papillomavirus, a sexually transmitted infection causing virtually all cervical cancer cases 
‡P-values based Pearson’s Chi-squared test. All calculated using non-missing data only 
§ Statistically significant at α=0.05 comparing worry about getting cervical cancer between White and 
Black women 
 
Most women were slightly worried or not at all worried about getting HPV 
infection (73.1% White; 71.8% Black)(Table 2). White women reported being more 
very/moderately worried about getting cervical cancer (52.6%) as compared to Black 
women (41.4%), p=0.004. Most women completely (41.1%) or moderately (40.6%) 
 Overall 
N=202 (%) White (n=78) 
Black 
(n=124) 
P-
value‡ 
How worried are you about getting HPV? 
Very/ moderately 
A little/ not at all 
 
46(22.8%) 
146 (72.3%) 
 
17 (21.8%) 
57 (73.1%) 
 
29 (23.4%) 
89 (71.8%) 
 
 
0.80 
How worried are you about getting cervical 
cancer? 
        Very/ moderately 
A little/ not at all 
  
 
41 (52.6%) 
34 (43.6%) 
 
 
39 (41.4%) 
77 (62.1%) 
 
 
 
0.004§ 
 
80 (39.6%) 
111 (55%) 
How much do you trust the self-test to give 
you accurate information about your risk 
for cervical cancer? 
Completely 
Moderately 
A little 
Not at all 
 
 
 
83 (41.1%) 
82 (40.6%) 
13 (6.4%) 
4 (2%) 
 
 
 
35(44.9%) 
26(33.3%) 
6 (7.7%) 
1 (1.3%) 
 
 
 
48 (38.7%) 
56(45.2%) 
7 (5.7%) 
3 (2.4%) 
 
 
 
 
0.45 
How often do you think an abnormal self-
test result means a woman is at risk for 
cervical cancer? 
Always 
Most of the time 
Some of the time 
Rarely 
 
 
 
18 (8.9%) 
37 (18.3%) 
76(37.6%) 
20 (9.9%) 
 
 
 
7 (9%) 
17 (21.8%) 
28 (35.9%) 
8 (10.3%) 
 
 
 
11(8.9%) 
20 (16.1%) 
48 (38.7%) 
12 (9.7%) 
 
 
 
 
0.83 
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trusted that the self-test gave accurate information about their risk for cervical cancer, 
with no differences observed by race. Approximately 9% of women thought an abnormal 
self-test always means that they are at risk for cervical cancer, though most believed that 
it indicated this risk most (18.3%) or some of the time (37.6%), regardless of race.  
Roughly half (49%) of the women strongly/moderately agreed that they were 
afraid of what the self-test results would say about their health, regardless of result or 
race (Table 3). 3.4% of women with a positive self-test result reported feeling 
embarrassed or ashamed by the results compared to no women with a negative result 
(p<0.001). Most women were not concerned that other people would hear their self-test 
results when they were delivered (93.3%); however a higher proportion of White women 
(65.8%) reported that they would share their self-test results, compared to Black women 
(44.6%), p=0.04. Women with positive self-test results were more likely to feel worried 
(34.5% positive, 1.2% negative; p=<0.001) and less likely to feel relieved (27.7 positive, 
83% negative; p< 0.001) by their results. More women with positive self-test results 
(31%) reported needing more help with understanding the results, compared to women 
with negative results (2.4%), p<0.01. Most women (73.2%) strongly/somewhat agreed 
that receiving their results over the phone was more private than receiving them over the 
mail. 90.7% of women strongly/somewhat agreed that they felt comfortable getting the 
results by phone. 62.4% of women strongly/somewhat agreed that receiving their results 
over the phone was more private than talking with their doctor in person. At follow up, 
90.3% of women reported understanding their self-test results. A higher proportion of 
women with positive self-test results (30%) reported that the results made them feel 
depressed compared to the women with negative self-test results (1.4%), p>0.001.
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Table 3: Reaction to self-test results provide to participants over the phone, stratified by positive versus negative HPV results and by reported race 
(N=194) † 
 Total (n, %) 
N=194 
Positive self-test 
result (n, %) 
n=29 
Negative self-test 
result (n, %) 
n=165 
P-value‡ 
 
White 
(n, %) 
n=73 
Black 
(n,%) 
n=121 
P-value‡ 
 
 
I was afraid what the self-test 
results would say about my health 
 
Strongly/moderately agree 
Strongly/moderately disagree 
 
 
 
95 (49%) 
95 (49%) 
 
 
 
14 (51.7%) 
14 (48.3%) 
 
 
 
80 (48.5%) 
81 (49.1%) 
 
 
 
 
0.68 
 
 
 
40 (54.8%) 
32 (43.8%) 
 
 
 
55 (45.5%) 
63 (52.%) 
 
 
 
 
0.41 
Do the results make you feel 
Embarrassed or ashamed 
 
Yes 
No 
 
 
 
1 (0.5%) 
156 (90.4%) 
 
 
 
1 (3.4%) 
22 (76.9%) 
 
 
 
0 (0%) 
134 (81.2%) 
 
 
 
 
<0.001§ 
 
 
 
1 (1.4%) 
53 (74%) 
 
 
 
0 (0%) 
102 (84.3%) 
 
 
 
 
0.31 
I was concerned that other people 
would hear my results  
 
Strongly/somewhat agree 
Strongly/somewhat disagree 
 
 
 
11(3.8%) 
181(93.3%) 
 
 
 
1(3.5%) 
28 (96.6%) 
 
 
 
10(6%) 
153(92.7%) 
 
 
 
 
0.36 
 
 
 
6 (8.2%) 
67 (91.8%) 
 
 
 
5 (4.1%) 
114 (94.2%) 
 
 
 
 
0.41 
Do you think you will share your 
self-test results with anyone?  
 
Yes  
 
         Spouse or Sexual Partner 
         Parent 
         Sibling/Brother/Sister/ 
         Other family member 
         Friend/Co-worker 
         Doctor 
         Other people with same 
         self-test result                     
         Not reported 
 
No 
 
 
 
102  (52.6%) 
 
50 (25.8%) 
8 (4.1%) 
20 (10.3%) 
 
15 (7.7%) 
2 (1%) 
1 (0.5%) 
 
7 (3.6%) 
 
61 (31.4%) 
 
 
 
14 (48.3%) 
 
6 (20.7%) 
0 (0%) 
6 (20.7%) 
 
1 (3.4%) 
1 (3.4%) 
0 (0%) 
 
0 (0%) 
 
10 (34.5%) 
 
 
 
88 (53.3%) 
 
44 (26.7%) 
8 (4.8%) 
14 (8.5%) 
 
14 (8.5%) 
1 (0.6%) 
1 (0.6%) 
 
7(4.2%) 
 
51 (30.9%) 
 
 
 
 
 
 
 
 
 
0.58 
 
 
 
 
 
48 (65.8%) 
 
25 (34.2%) 
3 (4.1%) 
8 (11%) 
 
8 (11%) 
0 (0%) 
0 (0%) 
 
4 (5.5%) 
 
12 (16.4%) 
 
 
 
54 (44.6%) 
 
25 (20.7%) 
5 (4.1%) 
12 (9.2%) 
 
7 (5.8%) 
2 (1.6%) 
1 (0.8%) 
 
3 (2.5%) 
 
49 (40.5%) 
 
 
 
 
 
 
 
 
 
0.04§ 
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Do the results make you feel 
worried? 
 
Yes 
No 
 
 
 
12 (6.2%) 
146(75.3%) 
 
 
 
10(34.5%) 
13 (44.8%) 
 
 
 
2(1.2%) 
133(80.6%) 
 
 
 
 
<0.001§ 
 
 
 
5 (6.9%) 
52 (71.2%) 
 
 
 
7 (5.8%) 
94 (77.7%) 
 
 
 
 
0.60 
Do the results make you feel 
relieved? 
 
Yes 
 No 
 
 
 
145 (74.7%) 
20(10.3%) 
 
 
 
8 (27.6%) 
14 (48.3%) 
 
 
 
137(83%) 
6 (3.6%) 
 
 
 
 
<0.001§ 
 
 
 
51 (69.9%) 
7 (9.6%) 
 
 
 
94 (77.7%) 
13 (10.7%) 
 
 
 
0.90 
Would you like help understanding 
the results?  
 
Yes 
No 
 
 
 
13 (6.7%) 
137 (7.6%) 
 
 
 
9 (31%) 
13 (44.8%) 
 
 
 
4 (2.4%) 
124 (75.2%) 
 
 
 
 
<0.001§ 
 
 
 
4 (5.5%) 
49 (67.1%) 
 
 
 
9 (7.5%) 
88 (72.7%) 
 
 
 
 
0.70 
Receiving my results over the 
phone is more private than 
receiving the results by mail.  
 
Strongly / somewhat agree  
Strongly / somewhat disagree  
 
 
 
 
142 (73.2%) 
31 (16%) 
 
 
 
 
23 (79.3%) 
3 (13.8%) 
 
 
 
 
119 (72.1%) 
27 (16.4%) 
 
 
 
 
 
0.52 
 
 
 
 
53 (72.6%) 
9 (12.3%) 
 
 
 
 
89 (76.5%) 
22 (18.2%) 
 
 
 
 
 
0.33 
I am comfortable getting self-test 
results by phone  
 
Strongly / somewhat agree  
Strongly / somewhat disagree  
 
 
 
176 (90.7%) 
5 (2.6%) 
 
 
 
29 (100%) 
0 (0%) 
 
 
 
147 (89.1%) 
5 (3%) 
 
 
 
 
0.56 
 
 
 
65 (89%) 
1 (1.4%) 
 
 
 
111 (91.7%) 
6 (5%) 
 
 
 
 
0.42 
Receiving my results over the 
phone is more private than talking 
with my doctor about them 
 
Strongly / somewhat agree  
Strongly / somewhat disagree 
 
 
 
 
121 (62.4%) 
43 (22.1%) 
 
 
 
 
20 (67%) 
3 (10.3%) 
 
 
 
 
101 (61.2%) 
40 (24.2%) 
 
 
 
 
 
0.30 
 
 
 
 
42 (57.5%) 
15 (20.6%) 
 
 
 
 
79 (65.3%) 
28 (23.1%) 
 
 
 
 
 
0.77 
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†AQ questions have M= 194 and includes all White and Black women who had either a positive or negative HPV self-test result. Indeterminate and 
missing results dropped from this analysis. FQ questions have N=93 and includes women who completed the FQ and meet the same criteria for AQ 
questions  
‡P-values based on Pearson’s Chi-squared test; calculated using non-missing data only 
 §Statistically significant at α=0.05
From follow-up questionnaire* Overall 
(N=93) 
Positive self-test 
result (n, %) 
N=20 
 
Negative self-test 
result (n, %) 
N=73 
 
P-value‡ 
White 
(n, %) 
N=35 
 
Black 
(n, %) 
N=58 
 
P-value‡ 
I understood my self-test results  
 
Strongly / somewhat agree  
Strongly / somewhat disagree 
 
 
84 (90.3%) 
1 (1.1%) 
 
 
19 (95%) 
1 (5%) 
 
 
65 (89%) 
0(0%) 
 
 
 
0.07 
 
 
32 (91.4%) 
0 (0%) 
 
 
52 (89.7%) 
1 (1.7%) 
 
 
 
0.43 
Did the self-test results make you 
feel depressed? 
 
       Yes 
       No 
 
 
 
7 (7.5%) 
76 (81.7%) 
 
 
 
6 (30%) 
13 (65%) 
 
 
 
1 (1.4%) 
63 (86.3%) 
 
 
 
 
<0.001§ 
 
 
 
3 (8.6%) 
29 (82.8%) 
 
 
 
4 (6.9%) 
47 (81%) 
 
 
 
 
0.81 
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Table 4:  Attitudes towards result delivery before results delivery and a median time of 
1.5 months after delivery to 95 infrequently screened women in North Carolina† 
 
                 Baseline                              n (%)           Follow-up                                  n (%) P-value‡ 
I am comfortable getting self-test results by 
phone  
 
Strongly / somewhat agree                89 (93.7%)                                                  
Strongly / somewhat disagree           2(2.1%)  
I felt comfortable getting my self-test results 
by phone.  
 
Strongly / somewhat agree           83 (87.4%)  
Strongly / somewhat disagree      3 (3.1%)  
 
 
 
0.85 
 
Receiving my results over the phone is more 
private than talking with my doctor about 
them  
 
Strongly / somewhat agree                60 (63.1%)                                                  
Strongly / somewhat disagree           22 (23.2%)                                                
Receiving my results over the phone is more 
private than talking with my doctor about 
them.  
 
Strongly / somewhat agree          52 (54.7%)                             
Strongly / somewhat disagree      31 (32.7%)  
 
 
 
0.07 
Receiving my results over the phone is more 
private than receiving the results by mail.  
 
Strongly / somewhat agree                69 (72.6%)                                                  
Strongly / somewhat disagree           19 (20%)                                                
Receiving my results over the phone is more 
private than receiving the results by mail.  
 
Strongly / somewhat agree          62 (65.3%) 
Strongly / somewhat disagree     17 (17.9%)  
  
 
 
0.22 
 
Would you like more help understanding the 
results?  
 
Yes                                                           9(9.5%) 
No                                                           69 (72.6%) 
Since you got your self-test results did you 
want more help understanding your results?  
 
Yes                                                     18 (19%) 
No                                                      67 (70.5%) 
 
 
 
0.01§ 
Actual HPV Self-Test Results  
 
Abnormal (positive)                             20 (21%) 
Negative                                                 73 (76.4%)  
Indeterminate                                       1(1.1%)  
 
Do you remember your HPV self-test results 
from this study? || 
Abnormal (positive)                       16 (16.8 %)                                              
Negative                                           65(68.4%)                                               
Indeterminate                                 1 (1.1%)                                                         
Don’t know                                      4 (4.2%)  
  
 
 
<0.001§
†N=95 includes participants who were asked all follow up questionnaire items and identified as 
white or black 
‡P-values based on Pearson’s Chi-squared test; calculated using non-missing data only 
§ Statistically significant at α=0.05 
 ||Respondents who reported “don’t know” or are missing received their self-test results  
HPV=Human papillomavirus, a sexually transmitted infection causing virtually all cervical cancer 
cases 
 
The median time between baseline and follow-up for the 95 women who 
completed both was 45 days, or 1.5 months (Table 4). The majority of women 
strongly/somewhat agreed being comfortable receiving HPV self-test results by phone at 
baseline (93.7%) and follow-up (87.4%). There was no significant variation over time 
among women who women strongly/somewhat agreed that receiving results over the 
 19 
phone was more private than talking with their doctor in person (63.1% at baseline; 
72.6% at follow- up), or that it was more private than receiving them in the mail (72.5% 
at baseline; 65% at follow-up). However, notably more women, reported wanting help 
understanding their results at follow-up (19%) as compared to baseline (9.5%), p<0.001. 
Most of these women had positive self-test results (Figure 2).  
 
 
Figure 2: Comparing women’s need for help understanding their HPV self-test results at 
baseline and follow-up 
 
 
 
 
 
 
 
 
 
 
 
 20 
Table 5: Predictors of strongly or moderately agreeing, “I was afraid what the self-test 
results would say about my health” (N=197) † 
  
 
 
 
 
Characteristic 
n (% women 
who 
strongly or 
moderately 
agreed with 
the statement 
that “I was 
afraid what the 
self-test results 
would say 
about my 
health”) 
Crude Odds 
ratios  
(95% 
Confidence 
Intervals)‡  
Adjusted Odds Ratios 
(by age and race) 
(95% Confidence 
Intervals)‡ 
Age (years) 
30-39 
40-49 
50+ 
 
32(47.8%) 
37 (50.7%) 
30 (52.6%) 
 
REF 
1.12 (0.58, 2.18) 
1.22 (0.60, 2.46) 
 
REF 
1.11 (0.57, 2.15) 
1.25 (0.61, 2.54) 
Race 
White 
African American 
 
42 (55.3%) 
57 (47.1%) 
 
REF 
0.72 (0.41, 1.28) 
 
REF 
0.71 (0.40, 1.27) 
Annual household income (USD) 
<$10,000 
$10,000 or greater 
 
44 (51.8%) 
48(49%) 
 
1.07 (0.63, 1.99) 
REF 
 
1.17 (0.66, 2.11) 
REF 
Education 
Less than GED or HS diploma 
High school diploma, GED  
Some college or more 
 
27 (65.9%) 
38 (52.1%) 
30(40%) 
 
2.89 (1.31, 6.40) 
1.62 (0.85, 3.12) 
REF 
 
2.92 (1.32, 6.50) 
1.73 (0.89, 3.36) 
REF 
Marital status 
Married or living as married 
Divorced/ separated/ widowed 
Single never married 
 
19 (39.6%) 
39 (61.9%) 
37 (48%) 
 
REF 
2.48 (1.15, 5.36) 
1.41(0.68, 2.93) 
 
REF 
2.37 (1.08, 5.19) 
1.49 (0.69, 3.1 
Time since last Pap (years)  
4-9 
≥10 or Never 
       >4 but Unspecified Duration 
 
56 (47.9%) 
18 (62.1%) 
25 (49%) 
 
REF 
1.78 (0.77, 4.10) 
1.05 (0.63, 1.32) 
 
REF 
2.69 (0.73, 3.92) 
1.09 (0.56. 2.10) 
Urbanicity 
Rural 
       Urban  
 
24 (63.2%) 
75(47.2%) 
 
1.92(0.92, 3.98) 
REF 
 
1.85 (0.89, 3.87) 
REF 
Smoking 
Smoker 
      Non-smoker 
 
53 (51.5%) 
45 (48.9%) 
 
1.11(0.64, 1.94) 
REF 
 
1.03 (0.58, 1.84) 
REF 
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Internet use 
Daily/Weekly 
Less often than that 
 
41(58.6%) 
54 (45%) 
 
REF 
0.58 (0.32, 1.05) 
 
REF 
0.58 (0.32, 1.07) 
Religious preference 
No religion 
Baptist 
Christian, non-Baptist 
Other religion 
 
11 (57.9%) 
39(52.7%) 
26 (43.3%) 
5 (50%) 
 
1.23 (0.44, 3.42) 
REF 
0.69 (0.35, 1.36) 
0.90 (0.21. 3.86) 
 
1.01 (0.35, 2.91) 
REF 
0.61 (0.30, 1.24) 
1.02 (0.23, 3.46 
Insurance 
Insured 
Non-insured 
 
68(54%) 
30 (42.9%) 
 
REF 
1.56(0.87, 2.82) 
 
REF 
1.56 (0.86, 2.81) 
Insurance 
None 
Medicaid 
Military/Blue Cross/Other 
 
68(54.4%) 
22 (44%) 
7(41.8%) 
 
1.49 (0.77, 2.88) 
REF 
0.89 (0.45, 2.72) 
 
1.44 (0.74, 2.80) 
REF 
0.78 (0.25, 2.45) 
Age at First Intercourse 
       < 16 
       ≥ 16 
 
30(50.9%) 
50 (55.6%) 
 
REF 
1.03 (0.54, 1.96) 
 
REF 
0.91 (0.46, 1.80 
Number of live births 
       0/1 
2 
       3+ 
 
28 (49.1%) 
28 (54.9%) 
40 (47.6%) 
 
REF 
1.26 (0.59, 2.69) 
0.94 (0.48.1.84) 
 
REF 
1.32 (0.61, 2.84) 
1.01 (0.51, 2.01) 
Need help reading written health 
materials 
Never 
      Rarely / Sometimes/ Often / 
Always 
 
 
80 (47.9%) 
18 (62.1%) 
 
 
REF 
1.78 (0.79, 3.99) 
 
 
REF 
1.60 (0.7 3.69) 
Current use of contraception 
Yes 
No 
Not needed (No sexual partner / post-
menopausal) 
 
38 (59.4%) 
23(44.2%) 
17 (48.6%) 
 
REF 
0.54 (0.26,1.14) 
0.64(0.28, 1.48) 
 
REF 
0.51 (0.24, 1.09) 
0.55 (0.23, 1.29) 
Completely comfortable using tampon 
Yes 
       No 
 
35 (47.9%) 
57 (52.3%) 
 
REF 
0.84 (0.46, 1.52) 
 
REF 
0.83 (0.46, 1.52) 
Self-reported history of abnormal Pap  
Never 
Once 
       Two or more times 
 
33 (47.8)% 
14 (58.3%) 
13 (41.9%) 
 
REF 
1.53 (0.59, 3.90) 
0.76 (0.33, 1.73) 
 
REF 
1.45 (0.56, 3.77) 
0.71 (0.29, 1.72) 
Self-reported history of HPV infection 
or cervical disease  
No  
       Yes 
 
 
92 (50%) 
5 (50%) 
 
 
REF 
1.00 (0.28, 3.57) 
 
 
REF 
0.87 (0.23, 3.20) 
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Self-reported history of genital 
warts  
 
No 
Yes 
 
 
87 (47.5%) 
10 (83.3%) 
 
 
REF 
5.52 (1.18, 25.88) 
 
 
REF 
5.45 (1.16, 
25.67) 
Self-reported history of sexually 
transmitted infections  
No 
Yes 
 
 
65 (48.2%) 
31 (52.5%) 
 
 
REF 
1.19 (0.65, 2.20) 
 
 
REF 
1.24 (0.66, 2.31) 
†Non-missing data for this question, excluding those who responded and ‘do not know’, or race other than 
White/Black)  
‡ Odds ratios calculated based on non-missing data only 
HPV=Human papillomavirus, a sexually transmitted infection causing virtually all cervical cancer cases 
§HPV knowledge index=score calculated based on number of correctly answered questions out of 5 total 
questions about HPV 
 
Predictors of strongly or moderately agreeing that the women were afraid of what 
the self-tests results would say about their health are depicted in table 5 and include 197 
women who answered this question in the AQ (Table 5). The majority of variables were 
not found to be statistically significant predictors, even when adjusted for age and race. 
However, women with less than a GED or high school diploma had 2.92 times the odds 
of strongly or moderately agreeing that they were afraid of what the self-test results 
would say about their health than women with some college education or more when 
adjusted for age and race (CI: 1.32, 6.5). Women who were divorced, separated, or 
widowed had 2.37 times the odds of strongly or moderately agreeing that they were 
afraid of what the self-test results would say about their health than women who were 
married or living as married, adjusted for age and race (CI: 1.08, 5.19). Furthermore, 
women who reported having genital warts had 5.45 times the odds of strongly or 
moderately agreeing with that they were afraid of what the self-test results would say 
about their health than women who did not, adjusted for age and race (CI: 1.16, 25.67). 
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DISCUSSION 
 Among over 200 infrequently screened women in North Carolina, White women 
reported being more concerned about getting cervical cancer and more willing to share 
their HPV self-test results with others as compared to Black women.  Regardless of race, 
women who received positive self-test results were more likely to feel embarrassed, 
worried, and depressed by their results. Conversely, women who received negative self-
test results were more likely to feel relieved by their results. Another key finding is that 
the women underestimated the need for help with interpreting their self-test results, 
particularly those with a positive result. Women were more likely to report being afraid 
of what the self-test results would say about their health if they had lower educational 
attainment; were divorced, widowed, and separated; and self-reported history of genital 
warts.   
Our findings that feelings of embarrassment, worry, and depression are not 
uncommon among women with positive self-test results were consistent with previous 
cervical cancer screening studies. Two studies on psychosocial impacts of abnormal Pap 
smears and positive HPV test results three European countries and the UK respectively 
showed that women reported initial feelings anxiety, panic and stress after being told 
their results over the phone. (23,24) More than half of the women in the European study 
had lingering feelings of worry or depression after discussing their test results and 
follow-up treatment after speaking with their gynecologist. (23) Additionally, the UK 
study findings support that women with visible genital warts were more likely to have 
negative psychosocial responses to positive results. (24) However, unlike our findings, 
data from a UK-based qualitative study on the social and psychological impact of HPV 
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testing showed that women were highly anxious about disclosing their results to family or 
close friends due to stigma associated with an STI such as HPV. (9) It is important to 
note that these studies did not specifically target typically hard to reach and racial 
minority women. Future studies of this nature should continue to focus on result delivery 
in these populations to better understand their reactions and how women can be 
counseled on their results in a culturally appropriate and respectful manner. 
  Confusion in interpreting cervical cancer screening results is a noted challenge, 
(9,22) particularly among underserved women. This may indicate a lack of counseling 
when women first receive their results, or a poor understanding of the information they 
receive. Addressing confusion regarding HPV self-test results is critical to its 
effectiveness; the low specificity of this test necessitates the follow up a positive result 
with a Pap smear and/or colposcopy in order to detect the presence of pre-cancerous 
cervical lesions or invasive cancer. Women must be able to understand their results in 
order to receive the appropriate follow-up care.  
This study highlights that women, especially those with positive results, may not 
immediately realize that they need help understanding their results, and result delivery 
should include referral to information sources that they can access for further clarification 
as needed. Women participating in this study were given a pamphlet with additional 
information regarding self-test results, and had access to a 24-hour toll-free hotline 
number that was staffed by trained personnel from ASHA.  The increase in women who 
reported wanting help interpreting their results at follow-up may also be associated with 
the delivery method. While the majority of women reported that receiving their results 
over the phone was more comfortable and private than speaking with a doctor in person, 
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it is possible that this delivery method limited the opportunity to ask questions or offer 
points of clarification since it was not possible for the women or the ASHA staff to pick 
up on visual cues of confusion. Furthermore, the women may have been less willing to 
ask clarifying questions over the phone than in person, an aspect that was not explicitly 
examined in this study.  
 This study had a number of strengths.  First, this study is the first we know of on 
feasibility of mailed HPV self-test screening among high-risk women in the United 
States.  Many US-based studies on self-test acceptability are clinic-based and asked about 
hypothetical acceptability of an at-home self-test, did not have the scope for 
understanding of reaction to results in this context.  Second, the acceptability 
questionnaire used in this study considered a variety of potential confounders, including 
those identified in existing literature. Additionally, the eligibility criteria controlled for 
income, appropriate age for HPV tests (30-65), concurrent pregnancy, and hysterectomy, 
allowing for a more homogenous study sample.  Furthermore, the study focused on North 
Carolina counties with relatively high incidences of cervical cancer, demonstrating the 
need for this research in this geographic area.  
 While this study had a relatively high enrollment and self-test return rate as 
compared to other cervical cancer screening studies targeting under-screened women, 
(26,27) it was not powered to include Hispanic/Latina women or analyze a large number 
of covariates relating to reactions to the HPV self-test. Second, there was a significant 
drop in complete data between the AQ and the FQ, as a large number of women did not 
complete the FQ after starting it. While loss to follow up is a common challenge, future 
studies of this nature should take measures to ensure that those who are reached for 
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follow up are able to complete it. A third limitation of this study is that not all questions 
pertaining to reactions to the HPV self-test results were included in both the AQ and FQ, 
making it difficult to fully assess the psychosocial impact of the results over time or the 
quality of the questions themselves. A future study of this nature should aim for more 
consistency between the baselines and follow up questionnaires. Ultimately, larger 
studies with a more nationally representative population are needed to support the 
evidence base for the findings of this study.  
Findings from this study can inform cervical cancer messaging to underserved 
populations by emphasizing and promoting their understanding of their heightened risk 
and the importance of screening. Given this study supports existing data that feelings of 
embarrassment, worry and depression are common among participants with positive HPV 
self-test results, result delivery should include counseling that addresses such 
psychosocial effects and their need for follow-up screening. Furthermore, the counseling 
should include referral to educational resources that women can access at any time to 
better understand or remind themselves of the meaning and implications of their results. 
As the first mailed HPV screening study among high-risk women in the United States, it 
underscores several emerging psychosocial considerations of result delivery and receipt 
that must be addressed in all components of cervical cancer screening outreach in a 
culturally appropriate and competent manner.      
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